IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,931 | -82.7% | 6,502 | -83.1% | 0.00% | -85.7% |
| Q3 2022 | $1,703,000 | -62.2% | 38,500 | -51.6% | 0.01% | -30.0% |
| Q4 2020 | $4,500,000 | +13.7% | 79,585 | -4.6% | 0.01% | 0.0% |
| Q3 2020 | $3,957,000 | -11.3% | 83,391 | +10.2% | 0.01% | -37.5% |
| Q2 2020 | $4,460,000 | -48.6% | 75,640 | -58.8% | 0.02% | -69.2% |
| Q1 2020 | $8,683,000 | -28.0% | 183,647 | -8.0% | 0.05% | -16.1% |
| Q4 2019 | $12,060,000 | -31.1% | 199,634 | -31.7% | 0.06% | -43.1% |
| Q3 2019 | $17,507,000 | +55.8% | 292,227 | +67.2% | 0.11% | +45.3% |
| Q2 2019 | $11,234,000 | -15.7% | 174,798 | +6.5% | 0.08% | -3.8% |
| Q1 2019 | $13,328,000 | +140.2% | 164,200 | +60.0% | 0.08% | +122.9% |
| Q4 2018 | $5,548,000 | +4.1% | 102,615 | -0.7% | 0.04% | +45.8% |
| Q3 2018 | $5,328,000 | – | 103,308 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |